HOME
Universe A-Z
PSYCH STOCK NEWS
PSYCH NEWS
RESEARCH
TESTIMONIALS
CLINICAL TRIALS
CONFERENCES
2024 PSYCHEDELIC INVESTOR CONFERENCE
Search
CLIENT
2023 Watch List
2024 WATCH LIST
ALCOHOL
CHARITY
CLIENT
CLINICAL TRIALS
CLINICS
CONFERENCES
DECK
INTERVIEW
INVESTORS
IPO
LARGE CAP PSYCH
NEO
PSYCH FUND | ETF
PSYCH NEWS
PSYCH STOCK NEWS
Psychedelic Investor Guide
Psychedelic Investor TV
RESEARCH
SIDE STORIES
STUFF
SUBSCRIBE
TESTIMONIALS
UNIVERSE
VETS
VIDEOS
Silo Pharma (SILO) Takes Aim at $3.1 Billion Fibromyalgia Market.
Editor | Curator
-
January 20, 2024
Psycheceutical’s (BWVI) Topical Ketamine: A Game-Changer for PTSD?
Editor | Curator
-
January 4, 2024
Psycheceutial Biosciences (BWVI) Listed on WeFunder!
Editor | Curator
-
November 1, 2023
Zappy Zapolin Hopes To Put Ibogaine Front And Center For Addiction
October 9, 2023
Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes
May 15, 2023
Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.)
May 15, 2023
Silo Pharma (SILO) Issues Letter to Shareholders
December 2, 2022
Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.
June 22, 2022
Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on...
October 16, 2021
Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida
October 13, 2021
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
October 2, 2021
Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide
September 27, 2021
Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company
September 24, 2021
1
2
Page 1 of 2